# OnCo record trevarx-biomedical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/trevarx-biomedical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "trevarx-biomedical" ;
  schema:name "Trevarx Biomedical"@en ;
  schema:alternateName "Trevarx Biomedical, Inc."@en, "Trevarx"@en ;
  schema:description "Trevarx Biomedical is a Philadelphia company attaching a radioactive atom to a PARP inhibitor so that radiation is released right at a tumour cell's DNA. Its first drug, AlphaPARP, is being prepared for ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/trevarx-biomedical/>, <https://www.trevarx.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.trevarx.com/>, <https://reporter.nih.gov/project-details/11408032> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/astatine-211-alpha-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/alphaparp/> .